David E. Lewandowski

David Lewandowski practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

David Lewandowski's NPI, 1316333198, was assigned on April 8, 2015. David Lewandowski holds Wisconsin license 66982-20.

David Lewandowski's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

David Lewandowski's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. David Lewandowski is also affiliated with Froedtert Menomonee Falls Hospital. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians. Dmand AI also links David Lewandowski to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where David Lewandowski practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is David Lewandowski's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. David Lewandowski is licensed in Wisconsin.

CMS data shows 1,893 Medicare services from David Lewandowski across 20 procedure codes in 2024, for 1,174 Medicare patients. Medicare paid $53,208 for them.

CMS counts 1,174 Medicare patients who saw David Lewandowski in 2024. The largest group is 65 to 74, with 493 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts David Lewandowski's median patient age at 69, with 51% women.

In 2024, David Lewandowski wrote 1,841 Medicare Part D claims for 335 patients. 69% of them were for generic drugs. CMS names the drug for 1,735 of them, across 33 drugs with 11 or more claims each, at $5,106,643 in total drug cost. In 2023, CMS named 780 claims across 21 drugs.

David Lewandowski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists David Lewandowski as offering telehealth.

Dmand AI links 9 papers to David Lewandowski, published from 2018 to 2024. 2023 was the busiest year, with 4. David Lewandowski has published most often in CASE (Phila). David Lewandowski's most frequent co-authors are Divyanshu Mohananey, MD, Noelle Christine Garster, MD, MS and Peter J. Mason, MD.

CMS Open Payments shows 60 general payments to David Lewandowski from 13 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 49% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,823.